Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9089 - 9096 of 12089 results
Can Alphabet Soup Fix Puerto Rico’s Debt Service Issues?
September 28, 2015| Blog| Viewpoint
Privacy Monday, September 28, 2015: More on US-EU Safe Harbor -- what's next?
September 28, 2015| Blog| Viewpoint
REMINDER: Register for Wednesday Webinar! Another Cop on the Cybersecurity Beat: What to Do Before and After the SEC and FINRA Come Knockin
September 28, 2015| Blog| Viewpoint
EB-5 Financing Basics: Video Series
September 28, 2015| Blog| Viewpoint
“Minor securities law violations in EB-5 deals don’t matter!” Nothing could be further from the truth! [VIDEO]
September 28, 2015| Blog| Viewpoint
The Evolution of Fiduciary Duties Under Delaware Law
September 28, 2015| Blog| Viewpoint
Can Alphabet Soup Fix Puerto Rico's Debt Service Issues?
September 28, 2015| Blog| Viewpoint
Washington Abuzz as Pope Francis, Xi Jinping Pass Through
September 25, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|